INSMED INC Marketable Securities (Non-Current)
INSMED INC (INSM) had Marketable Securities (Non-Current) of $0 as of 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:MarketableSecuritiesNoncurrent · last filed 2023-02-23
- 2022-12-31: Marketable Securities, Noncurrent $0.00.
- 2022-09-30: Marketable Securities, Noncurrent $0.00.
- 2022-06-30: Marketable Securities, Noncurrent $9.76M.
- 2022-03-31: Marketable Securities, Noncurrent $29.55M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-23 |
| 2022-09-30 | $0.00 10-Q · filed 2022-10-27 |
| 2022-06-30 | $9.76M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $29.55M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $50.04M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |